×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Selective Estrogen Receptor Degraders Therapeutic Market

ID: MRFR/HC/37374-HCR
128 Pages
Rahul Gotadki
October 2025

選択的エストロゲン受容体分解剤(SERD)治療薬市場調査レポート 用途別(乳がん、卵巣がん、子宮内膜がん、前立腺がん)、薬剤タイプ別(経口、静脈内、皮下)、作用機序別(選択的エストロゲン受容体分解、エストロゲン受容体調節、併用療法)、最終用途別(病院、専門クリニック、在宅ケア)および地域別(北米、ヨーロッパ、南米、アジア太平洋、中東、アフリカ) - 2034 年までの予測

共有
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Selective Estrogen Receptor Degraders Therapeutic Market Infographic
Purchase Options

Selective Estrogen Receptor Degraders Therapeutic Market 概要

Selective Estrogen Receptor Degraders Therapeutic Market市場の主要企業には以下が含まれます

レポートの範囲

コメントを残す

FAQs

What is the projected market valuation for the Selective Estrogen Receptor Degraders (SERD) Therapeutic Market by 2035?

The projected market valuation for the SERD Therapeutic Market is expected to reach 16.42 USD Billion by 2035.

What was the market valuation of the SERD Therapeutic Market in 2024?

The market valuation of the SERD Therapeutic Market was 4.205 USD Billion in 2024.

What is the expected CAGR for the SERD Therapeutic Market during the forecast period 2025 - 2035?

The expected CAGR for the SERD Therapeutic Market during the forecast period 2025 - 2035 is 13.18%.

Which key players are leading the SERD Therapeutic Market?

Key players in the SERD Therapeutic Market include AstraZeneca, Pfizer, Novartis, Eli Lilly and Company, Gilead Sciences, Bristol-Myers Squibb, Amgen, Merck & Co., and Sanofi.

What are the primary applications of SERDs in cancer treatment?

The primary applications of SERDs in cancer treatment include Breast Cancer, Ovarian Cancer, Endometrial Cancer, and Prostate Cancer.

How does the market for SERDs in Breast Cancer compare to other applications?

The market for SERDs in Breast Cancer is projected to grow from 1.5 USD Billion to 6.0 USD Billion, indicating a strong focus on this application.

What are the different drug types available in the SERD Therapeutic Market?

The SERD Therapeutic Market includes drug types such as Oral, Intravenous, and Subcutaneous, with Oral expected to grow from 1.5 USD Billion to 6.5 USD Billion.

What mechanisms of action are associated with SERDs?

Mechanisms of action for SERDs include Selective Estrogen Receptor Degradation, Estrogen Receptor Modulation, and Combination Therapies, with the former projected to grow significantly.

What is the expected growth in the end-use segment of the SERD Therapeutic Market?

The end-use segment for SERDs, particularly in Hospitals, is expected to grow from 1.6825 USD Billion to 6.728 USD Billion.

How do specialty clinics and homecare compare in the SERD Therapeutic Market?

Specialty Clinics and Homecare are projected to grow from 1.2615 USD Billion to 5.048 USD Billion and from 1.2615 USD Billion to 4.684 USD Billion, respectively.

無料サンプルをダウンロード

このレポートの無料サンプルを受け取るには、以下のフォームにご記入ください

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions